Case report showed Beau's lines or onychomadesis, not Muehrcke's lines

Basit Öğe Kaydı
dc.authorid0000-0001-9226-5134
dc.authorid0000-0003-1380-350X
dc.contributor.authorPolat, Mualla
dc.contributor.authorUzun, Özge
dc.date.accessioned2021-06-23T19:43:34Z
dc.date.available2021-06-23T19:43:34Z
dc.date.issued2016
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractTo the Editor, We wrote for the case report entitled ‘Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia’ presented by Dasanu et al.1 Our assessment is based on clinical photographs submitted by the researchers. It is well known that drug-induced nail abnormalities may result from toxicity to the matrix, the nail bed, or the periungual tissues. The most common symptoms include Beau’s lines, onychomadesis, melanonychia, onycholysis, periungual pyogenic granulomas, and Muehrcke’s lines. Nail changes usually affect several nails and in most cases are asymptomatic. Drugs that most frequently produce nail abnormalities include retinoids, indinavir, and cancer chemotherapeutic agents. In this case, it should be considered all differential diagnosis such as Muehrcke’s lines, Beau’s lines, or onychomadesis occurs due to drugs. In the presented case, we saw transverse white band on her nail plates after receiving 16-week transretinoic acid therapy for acute promyelocytic leukemia. But this cannot identify as a Muehrcke’s line. Because it does not appear the two horizontal white lines that run parallel to the lunula across the width of the nail which are specific for Muehrcke’s lines. Otherwise Muehrcke’s lines are nonpalpable.4 Moreover, we detected broken nail and grooves or furrows on the white nail plate. As a result, these are characteristic of Beau’s lines or onychomadesis not Muehrcke’s lines.en_US
dc.identifier.doi10.1177/1078155215610917
dc.identifier.endpage575en_US
dc.identifier.issn1078-1552
dc.identifier.issn1477-092X
dc.identifier.issue3en_US
dc.identifier.pmid26471737en_US
dc.identifier.scopus2-s2.0-84964253060en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage575en_US
dc.identifier.urihttps://doi.org/10.1177/1078155215610917
dc.identifier.urihttps://hdl.handle.net/20.500.12491/8805
dc.identifier.volume22en_US
dc.identifier.wosWOS:000374794300028en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorPolat, Mualla
dc.institutionauthorUzun, Özge
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofJournal Of Oncology Pharmacy Practiceen_US
dc.relation.publicationcategoryEditöre Mektup - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLeukonychia Striataen_US
dc.subjectTransretinoic Acid Therapy
dc.subjectAcute Promyelocytic Leukemia
dc.subjectBeau’s Lines
dc.titleCase report showed Beau's lines or onychomadesis, not Muehrcke's linesen_US
dc.typeLetteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
1078155215610917.pdf
Boyut:
106.56 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu